Clinical Trial Update: Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of TAK-850 administered by subcutaneous injection in healthy adults to evaluate safety and tolerability; results were posted in February 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Infection

Drugs mentioned

• TAK-850

Snippet

Sponsor: Takeda | Conditions: Influenza Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-02-17